Long-term correction of diabetic hyperglycemia through glucose-responsive hepatic insulin production using lentivirus
Journal Title: Journal of Diabetology and Endocrinology - Year 2017, Vol 2, Issue 1
Abstract
Type 1 diabetes mellitus (T1DM) is caused by the autoimmune destruction of the insulin-producing β cells of the pancreas. Insulin gene therapy is a promising strategy capable of overcoming the limitations of current treatments, but to become a viable option, it must provide long-term, glucose-responsive control of insulin production. We have previously achieved glucose-responsivity by incorporating glucose-inducible response elements (GIREs) upstream of a liver-specific insulin expression cassette (3xGIRE.ALB.Ins1-2xfur). In this study, 3xGIRE.ALB.Ins1-2xfur was delivered into streptozotocin-induced diabetic rats using lentivirus, resulting in remission of diabetic hyperglycemia for at least 482 days while restoring rate of weight gain in a dose-dependent fashion. Insulin immunostaining showed abundant insulin production in the liver, and qPCR showed 13-20 lentiviral integrations per cell in the liver of rats treated with high dose lentivirus. Negligible integration was found in the pancreas, kidney, spleen and muscle of LV-treated rats, confirming liver specificity. In vitro, LV.3xGIRE.ALB.Ins1-2xfur produced a 4.5-fold increase in insulin production in high glucose conditions, and in vivo, a 1.7-fold increase in insulin levels was found during an intraperitoneal glucose tolerance test. Unfortunately, limitations in large-scale lentivirus production and use of a tissue-specific promoter prevented treatment of more than one rat per batch of lentivirus. Thus, two of the LV-treated diabetic rats were undertreated, while another two rats were over treated, becoming hypoglycemic in the fed state. Nonetheless, we have established the framework for a long-term, glucose-responsive treatment for T1DM from which further improvements can be made.
Authors and Affiliations
Handorf AM, Sollinger HW, Alam T
Keywords
Related Articles
- EP ID EP556707
- DOI 10.14312/2398-0281.2017-1
- Views 46
- Downloads 0
Long-term correction of diabetic hyperglycemia through glucose-responsive hepatic insulin production using lentivirus
Type 1 diabetes mellitus (T1DM) is caused by the autoimmune destruction of the insulin-producing β cells of the pancreas. Insulin gene therapy is a promising strategy capable of overcoming the limitations of current trea...
A comparative analysis of pharmacists' self-confidence beliefs for regular U-500 (concentrated) insulin and U-100 insulin
The purpose of this research was to assess pharmacist confidence levels in the accurate and safe counseling on Humulin R regular U-500 (concentrated) insulin compared to U-100 insulin. The investigators developed a 34-it...
Disuse osteoporosis: A better understanding of pathophysiology may lead to potential therapies
Amputation results in mechanical unloading of a previously weight bearing limb with subsequent focal decrease in bone mineral density (BMD), and the development of disuse osteoporosis. We report the case of a 44-year-old...
Metformin in type 2 diabetes: where is the evidence?
Taking into consideration the main evidence available in 2015, Boussageon contest the status of metformin as the first -line treatment for DT2 patients. He contends that as regards macrovascular and microvascular complic...
Protocol of the DiaDec-study: Quality of life, health care utilisation and costs in patients with diabetes: The role of depression
Diabetes is a highly prevalent chronic disease with a substantial impact on quality of life and societal cost. Depressive disorders have been found to be more prevalent among individuals with diabetes than those without...